Citigroup
ARRY

Citigroup’s Array Biopharma Inc ARRY Stock Holding History

Citigroup’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-65,500
Closed -$3.04M – 7952
2019
Q2 		$3.04M Sell
65,500
-7,000
-10% -$197K ﹤0.01% 2388
2019
Q1 		$1.77M Buy
72,500
+44,100
+155% +$918K ﹤0.01% 2779
2018
Q4 		$405K Sell
28,400
-16,900
-37% -$256K ﹤0.01% 4357
2018
Q3 		$689K Buy
45,300
+1,600
+4% +$24.5K ﹤0.01% 3894
2018
Q2 		$733K Buy
43,700
+30,300
+226% +$482K ﹤0.01% 3687
2018
Q1 		$219K Sell
13,400
-17,300
-56% -$277K ﹤0.01% 4874
2017
Q4 		$393K Sell
30,700
-34,900
-53% -$397K ﹤0.01% 4352
2017
Q3 		$807K Buy
65,600
+51,400
+362% +$477K ﹤0.01% 3606
2017
Q2 		$119K Sell
14,200
-900
-6% -$7.36K ﹤0.01% 5220
2017
Q1 		$135K Sell
15,100
-32,400
-68% -$345K ﹤0.01% 4981
2016
Q4 		$418K Sell
47,500
-13,500
-22% -$99.3K ﹤0.01% 4565
2016
Q3 		$412K Buy
+61,000
New +$236K ﹤0.01% 4075

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Citigroup's ARRY Position: Q3 2019 in Review

Citigroup sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,539,322 shares — an estimated $71.3M sold.

Citigroup first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $71.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Citigroup reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Citigroup sold 1,539,322 Array Biopharma Inc shares in Q3 2019, an estimated $71.3M.
  • Citigroup first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
  • Citigroup's Array Biopharma Inc position peaked at $71.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.